JP2005536503A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005536503A5 JP2005536503A5 JP2004520900A JP2004520900A JP2005536503A5 JP 2005536503 A5 JP2005536503 A5 JP 2005536503A5 JP 2004520900 A JP2004520900 A JP 2004520900A JP 2004520900 A JP2004520900 A JP 2004520900A JP 2005536503 A5 JP2005536503 A5 JP 2005536503A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- formula
- compound
- pharmaceutically acceptable
- prodrug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 6
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 102000031052 Ceramide glucosyltransferases Human genes 0.000 claims 1
- 108091000115 Ceramide glucosyltransferases Proteins 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000000546 pharmaceutic aid Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 229940002612 prodrugs Drugs 0.000 claims 1
- 125000006239 protecting group Chemical group 0.000 claims 1
- 238000006268 reductive amination reaction Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- RZLAXWZVPCMNHD-NMTNWJIDSA-N C[C@@H](C(Nc1ccc(CN(C[C@@H](C2O)O)[C@@H](CO)[C@H]2O)cc1)=O)c1ccccc1 Chemical compound C[C@@H](C(Nc1ccc(CN(C[C@@H](C2O)O)[C@@H](CO)[C@H]2O)cc1)=O)c1ccccc1 RZLAXWZVPCMNHD-NMTNWJIDSA-N 0.000 description 1
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0216656A GB0216656D0 (en) | 2002-07-17 | 2002-07-17 | Novel compounds |
GB0301480A GB0301480D0 (en) | 2003-01-22 | 2003-01-22 | Novel compounds |
GB0313679A GB0313679D0 (en) | 2003-06-13 | 2003-06-13 | Novel compounds |
PCT/GB2003/003099 WO2004007453A1 (en) | 2002-07-17 | 2003-07-17 | Piperidinetriol derivatives as inhibitors of glycosylceramide synthase |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2005536503A JP2005536503A (ja) | 2005-12-02 |
JP2005536503A5 true JP2005536503A5 (US06894165-20050517-C00155.png) | 2006-09-07 |
JP4575156B2 JP4575156B2 (ja) | 2010-11-04 |
Family
ID=30118831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004520900A Expired - Fee Related JP4575156B2 (ja) | 2002-07-17 | 2003-07-17 | グルコシルセラミドシンターゼの阻害剤としてのピペリジントリオール誘導体 |
Country Status (7)
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0100889D0 (en) | 2001-01-12 | 2001-02-21 | Oxford Glycosciences Uk Ltd | Compounds |
EP1534676B1 (en) | 2002-07-17 | 2012-09-12 | Actelion Pharmaceuticals Ltd. | Piperidinetriol derivatives as inhibitors of glycosylceramide synthase |
JP4585851B2 (ja) * | 2002-07-17 | 2010-11-24 | アクテリオン ファーマシューティカルズ リミテッド | グルコシルセラミドシンターゼの阻害剤としてのピペリジントリオール誘導体 |
GB0313677D0 (en) * | 2003-06-13 | 2003-07-16 | Oxford Glycosciences Uk Ltd | Novel compound |
GB0313678D0 (en) | 2003-06-13 | 2003-07-16 | Oxford Glycosciences Uk Ltd | Novel compounds |
EP1528056A1 (en) * | 2003-10-29 | 2005-05-04 | Academisch Ziekenhuis bij de Universiteit van Amsterdam | Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors |
US20060025449A1 (en) * | 2004-03-25 | 2006-02-02 | United Therapeutics | Use of N-substituted imino sugars for appetite suppression |
US8003617B2 (en) | 2004-11-10 | 2011-08-23 | Genzyme Corporation | Methods of treating diabetes mellitus |
PT2032134E (pt) | 2006-05-09 | 2015-10-07 | Genzyme Corp | Métodos de tratamento da doença do fígado gorduroso |
EP2594565B1 (en) | 2007-05-31 | 2018-10-24 | Genzyme Corporation | 2-acylaminopropanol-type glucosylceramide synthase inhibitors |
EP2209473B1 (en) | 2007-10-05 | 2017-11-22 | Genzyme Corporation | Method of treating polycystic kidney diseases with ceramide derivatives |
US8389517B2 (en) * | 2008-07-28 | 2013-03-05 | Genzyme Corporation | Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease |
MX2011003517A (es) | 2008-10-03 | 2011-05-25 | Genzyme Corp | Inhibidores de la glucosilceramida sintasa tipo 2-acilaminopropanol. |
WO2011085544A1 (zh) * | 2010-01-13 | 2011-07-21 | 安徽辉克药业有限公司 | 有效清除肿瘤细胞的化合物 |
EP3673906A1 (en) * | 2011-03-18 | 2020-07-01 | Genzyme Corporation | Glucosylceramide synthase inhibitors |
MA37975B2 (fr) | 2012-09-11 | 2021-03-31 | Genzyme Corp | Inhibiteurs de synthase de glucosylcéramide |
SG10201903630UA (en) * | 2014-11-05 | 2019-05-30 | Emergent Virology Llc | Iminosugars useful for the treatment of viral diseases |
WO2017087364A1 (en) * | 2015-11-16 | 2017-05-26 | Ptc Therapeutics, Inc. | Hydrogen isotope-enriched analogues of 1,2,4-oxandiazole benzoic acid compounds, compositions and uses thereof |
EP4146623A4 (en) * | 2020-05-07 | 2024-05-01 | Alectos Therapeutics Inc. | NON-LYSOSOMA GLUCOSYLCERAMIDAS INHIBITORS AND THEIR USES |
US20230174486A1 (en) * | 2020-05-07 | 2023-06-08 | ALECTOS THERAPEUTICS lNC. | Non-lysosomal glucosylceramidase inhibitors and uses thereof |
IL300090A (en) | 2020-07-24 | 2023-03-01 | Genzyme Corp | Pharmaceutical preparations containing VENGLUSTAT |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3495570A (en) * | 1967-07-03 | 1970-02-17 | Amchem Prod | Applicator for liquid chemical conversion coating material |
NO154918C (no) | 1977-08-27 | 1987-01-14 | Bayer Ag | Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin. |
DE3007078A1 (de) | 1980-02-26 | 1981-09-10 | Bayer Ag, 5090 Leverkusen | Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung |
DE3024901A1 (de) | 1980-07-01 | 1982-01-28 | Bayer Ag, 5090 Leverkusen | Herbizide mittel auf basis von piperidin-derivaten |
DE3247615A1 (de) * | 1982-12-23 | 1984-07-05 | Hoechst Ag, 6230 Frankfurt | Substituierte phenylsulfonyloxybenzimidazolcarbaminate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
DE3737523A1 (de) * | 1987-11-05 | 1989-05-18 | Bayer Ag | Verwendung von substituierten hydroxypiperidinen als antivirale mittel |
US5003072A (en) * | 1988-11-03 | 1991-03-26 | G. D. Searle & Co. | 1,5-dideoxy-1,5-imino-D-glucitol derivatives |
JPH02306962A (ja) | 1989-05-19 | 1990-12-20 | Meiji Seika Kaisha Ltd | 新規n―置換―1―デオキシノジリマイシン誘導体及びそれを含有する癌細胞転移抑制剤 |
JPH0324057A (ja) | 1989-06-22 | 1991-02-01 | Tosoh Corp | ポリヒドロキシピペリジン類及びその製造法 |
KR920703056A (ko) | 1989-09-07 | 1992-12-17 | 아만 히데아키 | 항 바이러스제 |
WO1992000277A1 (fr) * | 1990-06-29 | 1992-01-09 | Nippon Shinyaku Co., Ltd. | Derive de piperidine |
US5276120A (en) * | 1991-05-30 | 1994-01-04 | The Scripps Research Institute | Process for forming omega-deuxy-azasugars |
WO1994025603A1 (de) | 1993-05-05 | 1994-11-10 | Boehringer Mannheim Gmbh | Cholesterinoxidase aus brevibacterium sterolicum |
US5798366A (en) | 1993-05-13 | 1998-08-25 | Monsanto Company | Method for treatment of CNS-involved lysosomal storage diseases |
US6291657B1 (en) | 1993-05-13 | 2001-09-18 | Monsanto Company | Deoxygalactonojirimycin derivatives |
EP0912179B1 (en) | 1996-07-15 | 2006-04-12 | MacroZyme DNM B.V. | Deoxynojirimycin derivatives and their uses as glucosylceramidase inhibitors |
HUP0003362A3 (en) | 1997-05-06 | 2001-04-28 | Novo Nordisk As | Piperidine derivatives and pharmaceutical compositions containing them |
WO1999001555A1 (en) | 1997-07-03 | 1999-01-14 | The United States Of America Represented By The Secretary, Department Of Health And Human Services | Genes for niemann-pick type c disease |
MY122499A (en) * | 1997-11-10 | 2006-04-29 | Searle & Co | Use of alkylated iminosugars to treat multidrug resistance |
US6610703B1 (en) | 1998-12-10 | 2003-08-26 | G.D. Searle & Co. | Method for treatment of glycolipid storage diseases |
WO2000056334A1 (en) | 1999-03-19 | 2000-09-28 | The Trustees Of Boston College | Use of imino sugars for anti-tumor therapy |
GB0100889D0 (en) * | 2001-01-12 | 2001-02-21 | Oxford Glycosciences Uk Ltd | Compounds |
GB9909064D0 (en) * | 1999-04-20 | 1999-06-16 | Oxford Glycosciences Uk Ltd | Therapies |
ATE234626T1 (de) | 1999-07-26 | 2003-04-15 | Searle & Co | Verwendung von langkettigen n-alkyl derivaten von deoxynojirimycin mit glucocerebrosidase enzyme zur herstellung eines medikaments zur behandlung von mit glykolipiden akkumulation zusammenhängenden krankheiten |
US7256005B2 (en) * | 1999-08-10 | 2007-08-14 | The Chancellor, Masters And Scholars Of The University Of Oxford | Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity |
EP1210082B1 (en) | 1999-08-10 | 2008-01-02 | The Chancellor, Masters And Scholars Of The University Of Oxford | Long chain n-alkyl compounds and oxa-derivatives thereof and use as antiviral compositions |
AU2003216664A1 (en) | 2002-03-13 | 2003-09-22 | Aarnoud C. Van Der Spoel | A non-hormonal approach to male contraception |
EP1534676B1 (en) | 2002-07-17 | 2012-09-12 | Actelion Pharmaceuticals Ltd. | Piperidinetriol derivatives as inhibitors of glycosylceramide synthase |
JP4585851B2 (ja) * | 2002-07-17 | 2010-11-24 | アクテリオン ファーマシューティカルズ リミテッド | グルコシルセラミドシンターゼの阻害剤としてのピペリジントリオール誘導体 |
GB0313677D0 (en) | 2003-06-13 | 2003-07-16 | Oxford Glycosciences Uk Ltd | Novel compound |
GB0313678D0 (en) | 2003-06-13 | 2003-07-16 | Oxford Glycosciences Uk Ltd | Novel compounds |
GB0400812D0 (en) | 2004-01-14 | 2004-02-18 | Celltech R&D Ltd | Novel compounds |
-
2003
- 2003-07-17 EP EP03764025A patent/EP1534676B1/en not_active Expired - Lifetime
- 2003-07-17 CA CA2492404A patent/CA2492404C/en not_active Expired - Fee Related
- 2003-07-17 WO PCT/GB2003/003099 patent/WO2004007453A1/en active Application Filing
- 2003-07-17 US US10/522,208 patent/US7985760B2/en not_active Expired - Fee Related
- 2003-07-17 ES ES03764025T patent/ES2393331T3/es not_active Expired - Lifetime
- 2003-07-17 AU AU2003246942A patent/AU2003246942B2/en not_active Ceased
- 2003-07-17 JP JP2004520900A patent/JP4575156B2/ja not_active Expired - Fee Related